BR9507656A - Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto - Google Patents
Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um compostoInfo
- Publication number
- BR9507656A BR9507656A BR9507656A BR9507656A BR9507656A BR 9507656 A BR9507656 A BR 9507656A BR 9507656 A BR9507656 A BR 9507656A BR 9507656 A BR9507656 A BR 9507656A BR 9507656 A BR9507656 A BR 9507656A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pain
- processes
- preparation
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9401727A SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds I |
| PCT/SE1995/000504 WO1995031464A1 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9507656A true BR9507656A (pt) | 1997-09-23 |
Family
ID=20394058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9507656A BR9507656A (pt) | 1994-05-18 | 1995-05-09 | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5886001A (pt) |
| EP (1) | EP0759923A1 (pt) |
| JP (1) | JPH10500132A (pt) |
| CN (1) | CN1152314A (pt) |
| AU (1) | AU690281B2 (pt) |
| BR (1) | BR9507656A (pt) |
| CA (1) | CA2189139A1 (pt) |
| FI (1) | FI964576A (pt) |
| HU (1) | HU9603171D0 (pt) |
| IL (1) | IL113627A0 (pt) |
| IS (1) | IS4381A (pt) |
| NO (1) | NO964871D0 (pt) |
| NZ (1) | NZ287177A (pt) |
| PL (1) | PL317250A1 (pt) |
| SE (1) | SE9401727D0 (pt) |
| SK (1) | SK139696A3 (pt) |
| WO (1) | WO1995031464A1 (pt) |
| ZA (1) | ZA953699B (pt) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2205664C (en) * | 1995-09-26 | 2008-05-20 | Toray Industries, Inc. | Indole derivatives and medicinal use thereof |
| NZ331769A (en) * | 1997-01-16 | 2000-05-26 | Toray Industries | Indolomorphinan derivative and agent for curing and preventing cerebral disorder |
| GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
| AU5344799A (en) * | 1998-08-06 | 2000-02-28 | Robert M Jones | Kappa (op2) opioid receptor antagonists |
| US7232829B2 (en) | 2001-04-06 | 2007-06-19 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
| WO2002080919A1 (en) * | 2001-04-06 | 2002-10-17 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| KR20140015122A (ko) | 2003-10-01 | 2014-02-06 | 아돌로 코포레이션 | 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법 |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US20080119452A1 (en) | 2006-09-12 | 2008-05-22 | Dolle Roland E | Methods for enhancing cognitive function |
| US9321116B2 (en) * | 2009-03-05 | 2016-04-26 | United Technologies Corporation | Cold metal transfer gas metal arc welding apparatus and method of operation |
| EP2340832A1 (en) | 2009-12-23 | 2011-07-06 | Universität Innsbruck | Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
| EP2655332B1 (en) | 2010-12-23 | 2016-07-13 | Phoenix Pharmalabs, Inc. | Novel morphinans useful as analgesics |
| WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
| AU2013257706A1 (en) | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for the treatment of neurological disorders |
| CA2873093A1 (en) | 2012-05-07 | 2013-11-14 | Cellixbio Private Limited | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
| US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
| WO2013167992A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory disorders |
| WO2013168025A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of blood clotting disorders |
| US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
| US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
| WO2013168023A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of parkinson's disease |
| US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
| US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
| US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
| WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
| US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
| US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
| US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
| WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
| WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
| WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
| US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
| WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
| WO2013168005A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
| US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
| JP2015518854A (ja) | 2012-05-23 | 2015-07-06 | セリックスビオ プライヴェート リミテッド | 多発性硬化症の治療のための組成物および方法 |
| WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
| SG11201407326XA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of mucositis |
| US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
| WO2013175357A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory bowel disease |
| US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
| WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
| WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
| SG11201407325YA (en) | 2012-09-08 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of inflammation and lipid disorders |
| HU231191B1 (hu) | 2013-04-15 | 2021-08-30 | Szegedi Tudományegyetem | Izotóp tartalmú morfin molekulák |
| US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
| AU2014276346A1 (en) | 2013-06-04 | 2015-12-24 | Cellixbio Private Limited | Compositions and methods for the treatment of diabetes and pre-diabetes |
| WO2015082932A1 (en) | 2013-12-05 | 2015-06-11 | The University Of Bath | Novel opioid compounds and their uses |
| US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
| CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
| EP3201168B1 (en) | 2014-09-29 | 2020-03-18 | Cellix Bio Private Limited | Compounds and compositions for the treatment of multiple sclerosis |
| CA2965449C (en) | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
| US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
| US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
| US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
| US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
| US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
| US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
| US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
| CN107405343A (zh) | 2014-11-07 | 2017-11-28 | 明尼苏达大学董事会 | 可用于治疗疾病的盐和组合物 |
| US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
| US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
| ES2905771T3 (es) | 2015-01-06 | 2022-04-12 | Cellix Bio Private Ltd | Composiciones y procedimientos para el tratamiento de la inflamación y del dolor |
| WO2017165558A1 (en) | 2016-03-22 | 2017-09-28 | Regents Of The University Of Minnesota | Combination for treating pain |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
| US5223507A (en) * | 1992-01-21 | 1993-06-29 | G. D. Searle & Co. | Method of using opioid compounds as delta opioid selective agonist analgesics |
| US5225417A (en) * | 1992-01-21 | 1993-07-06 | G. D. Searle & Co. | Opioid agonist compounds |
| EP0846694A1 (en) * | 1992-01-23 | 1998-06-10 | Toray Industries, Inc. | Morphinan derivative and its pharmaceutical applications |
| EP0614898B1 (en) * | 1992-09-29 | 2003-05-07 | Toray Industries, Inc. | Indole derivative, process for producing the same, and medicinal use thereof |
| US5464841A (en) * | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| US5780479A (en) * | 1997-04-04 | 1998-07-14 | Regents Of The University Of Minnesota | Use of opioid antagonists to treat impulse-control disorders |
-
1994
- 1994-05-18 SE SE9401727A patent/SE9401727D0/xx unknown
-
1995
- 1995-05-07 IL IL11362795A patent/IL113627A0/xx unknown
- 1995-05-08 ZA ZA953699A patent/ZA953699B/xx unknown
- 1995-05-09 BR BR9507656A patent/BR9507656A/pt not_active Application Discontinuation
- 1995-05-09 HU HU9603171A patent/HU9603171D0/hu unknown
- 1995-05-09 NZ NZ287177A patent/NZ287177A/en unknown
- 1995-05-09 SK SK1396-96A patent/SK139696A3/sk unknown
- 1995-05-09 CA CA002189139A patent/CA2189139A1/en not_active Abandoned
- 1995-05-09 PL PL95317250A patent/PL317250A1/xx unknown
- 1995-05-09 CN CN95194032A patent/CN1152314A/zh active Pending
- 1995-05-09 EP EP95920329A patent/EP0759923A1/en not_active Withdrawn
- 1995-05-09 JP JP7529554A patent/JPH10500132A/ja not_active Abandoned
- 1995-05-09 US US08/507,365 patent/US5886001A/en not_active Expired - Fee Related
- 1995-05-09 WO PCT/SE1995/000504 patent/WO1995031464A1/en not_active Application Discontinuation
- 1995-05-09 AU AU25818/95A patent/AU690281B2/en not_active Ceased
-
1996
- 1996-11-08 IS IS4381A patent/IS4381A/is unknown
- 1996-11-15 NO NO964871A patent/NO964871D0/no not_active Application Discontinuation
- 1996-11-15 FI FI964576A patent/FI964576A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995031464A1 (en) | 1995-11-23 |
| AU690281B2 (en) | 1998-04-23 |
| FI964576A0 (fi) | 1996-11-15 |
| EP0759923A1 (en) | 1997-03-05 |
| SE9401727D0 (sv) | 1994-05-18 |
| PL317250A1 (en) | 1997-04-01 |
| FI964576A (fi) | 1996-11-15 |
| IS4381A (is) | 1996-11-08 |
| SK139696A3 (en) | 1997-05-07 |
| AU2581895A (en) | 1995-12-05 |
| CA2189139A1 (en) | 1995-11-23 |
| US5886001A (en) | 1999-03-23 |
| ZA953699B (en) | 1995-11-20 |
| CN1152314A (zh) | 1997-06-18 |
| IL113627A0 (en) | 1995-08-31 |
| NO964871L (no) | 1996-11-15 |
| HU9603171D0 (en) | 1997-01-28 |
| NZ287177A (en) | 1997-11-24 |
| JPH10500132A (ja) | 1998-01-06 |
| NO964871D0 (no) | 1996-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
| BR9610248A (pt) | Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
| BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
| BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| BR9702147A (pt) | Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica | |
| BR9706822A (pt) | Composição kit processo para tratamento de um distúrbio respiratório e utilização da composição do kit de formoterol de um sal ou solvato farmaceuticamente aceitável do mesmo e de budesonida | |
| BR9608908A (pt) | Composto composição farmacêutica processos para aliviar dor e para preparar um composto | |
| BR9707003A (pt) | Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto | |
| BR9608405A (pt) | Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico | |
| BR9707489A (pt) | Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico | |
| BR9505610A (pt) | Composto composição farmacéutica processo para a preparação de um composto uso e método de tratar inflamação e dor | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| BR9711311A (pt) | Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem | |
| BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
| BR9610733A (pt) | Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto | |
| BR9607346A (pt) | Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos | |
| BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
| EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
| DE69620691T2 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
| BR9710376A (pt) | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano | |
| BR9707210A (pt) | Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos | |
| BR9611234A (pt) | Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |